U.S. markets open in 2 hours 16 minutes
  • S&P Futures

    4,036.50
    +35.00 (+0.87%)
     
  • Dow Futures

    32,839.00
    +251.00 (+0.77%)
     
  • Nasdaq Futures

    12,839.75
    +107.25 (+0.84%)
     
  • Russell 2000 Futures

    1,785.40
    +20.60 (+1.17%)
     
  • Crude Oil

    74.09
    +0.89 (+1.22%)
     
  • Gold

    1,969.60
    -3.90 (-0.20%)
     
  • Silver

    23.41
    -0.01 (-0.06%)
     
  • EUR/USD

    1.0860
    +0.0013 (+0.1195%)
     
  • 10-Yr Bond

    3.5640
    0.0000 (0.00%)
     
  • Vix

    19.25
    -1.35 (-6.55%)
     
  • GBP/USD

    1.2349
    +0.0011 (+0.0901%)
     
  • USD/JPY

    131.9430
    +1.0680 (+0.8160%)
     
  • BTC-USD

    28,299.34
    +1,541.26 (+5.76%)
     
  • CMC Crypto 200

    617.81
    +375.13 (+154.58%)
     
  • FTSE 100

    7,544.72
    +60.47 (+0.81%)
     
  • Nikkei 225

    27,883.78
    +365.53 (+1.33%)
     

Certara to Participate in Upcoming Investor Conferences

Certara
Certara

PRINCETON, N.J., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor conferences:

  • Jeffries London Healthcare Conference
    Date and Time: Tuesday, November 15 at 4:25PM GMT

  • Stephens Annual Investment Conference
    Date and Time: Thursday, November 17 at 9:00AM CT

Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.

About Certara
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.

Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com

Media Contact:
Daniel Yunger
Kekst CNC
daniel.yunger@kekstcnc.com